Cipla

Sudarshan Sukhani: BUY Titan, Cipla, UltraTech Cement; SELL Tata Steel

Sukant Sharma 17 September 2020
Sudarshan Sukhani: BUY Titan, Cipla, UltraTech Cement; SELL Tata Steel

Technical analyst Sudarshan Sukhani has suggested three BUY Calls and one SELL Call for today’s trading session.

Ashwani Gujral: BUY Cipla, Biocon; SELL Axis Bank, Bajaj Finance and Prestige Estate

Neeta Aurora 10 September 2020
Ashwani Gujral: BUY Cipla, Biocon; SELL Axis Bank, Bajaj Finance and Prestige Estate

Ashwani Gujral: BUY IndusInd Bank, SBI, Kotak Mahindra Bank, Sun Pharma and Godrej Consumer

Sukant Sharma 1 September 2020
Ashwani Gujral: BUY IndusInd Bank, SBI, Kotak Mahindra Bank, Sun Pharma and Godrej Consumer

Market analyst Ashwani Gujral has suggested five BUY Calls and no SELL calls for today’s trade, suggesting a bullish view for bounce-back in Indian markets after yesterday’s decline.

Ashwani Gujral: BUY Cipla, Dr Reddy’s, Tata Steel, UPL and Bharti Infratel

Sukant Sharma 30 July 2020
Ashwani Gujral: BUY Cipla, Dr Reddy’s, Tata Steel, UPL and Bharti Infratel

Market analyst Ashwani Gujral has suggested five BUY calls and no SELL call for today’s session, suggesting a bullish outlook for markets.

Sanjiv Bhasin IIFL Securities: Lupin, Cipla, IPCA Labs, Cadila and Dr Lal Path Labs look interesting

Shalini Kakkad 23 July 2020
Sanjiv Bhasin IIFL Securities: Lupin, Cipla, IPCA Labs, Cadila and Dr Lal Path Labs look interesting

Market expert Sanjiv Bhasin has suggested five stocks for investors and medium-term outlook traders for August in the pharmaceutical segment.

Controversy about Gilead’s Remdesivir in India due to low production and black market sale

Nandini Mehta 14 July 2020
Controversy about Gilead’s Remdesivir in India due to low production and black market sale

Gilead Sciences signed a contract with four Indian pharmaceutical companies to produce its medication ‘Remdesivir’ which has been found effective in treatment of some COVID-19 patients.

Pages